In particular, high protein levels of YB-1 and MTA1 within PIN lesions are significantly associated with a shorter time to PSA relapse as well as a three fold increased risk for requiring future androgen deprivation therapy or radiation therapy (Figures 2B and 2C). The gene discussed is MTA1; the disease is prostate intraepithelial neoplasia.